24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Private Equity
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
10:38
Ilya Sutskever pushes back against Musk in OpenAI lawsuit
10:18
Full list of Israeli startup M&As in 2025
10:15
HubSpot acquires 10-month-old Israeli AI startup XFunnel in first local deal
09:49
Why did Navan lose $1 billion in market value on its first day on Wall Street?
More stories
Buzz
Most popular
Daily
Weekly
1
Figma acquires one-year-old Israeli AI startup Weavy for over $200 million
2
Oren Zeev turns early Navan bet into $1 billion payday
3
Varonis shares plunge 45% after surprise earnings miss
4
How AI is rewriting the rules of salary negotiation
5
Inside the Shin Bet’s secret startup factory
More news
Private Equity
13 stories about Private Equity
The titans are back: Foreign private equity funds show renewed presence in Israel
29.10.25
|
Nimrod Rosenblum
"Foreign equity has not disappeared; it simply evolved. Beyond the flashy Nasdaq exits, a new wave of steady, meaningful private equity transactions is reshaping the market," writes Nimrod Rosenblum, Managing Partner and Head of Corporate, Mergers & Acquisitions at Epstein Rosenblum Maoz (ERM) Law Firm.
Foreign private equity funds: A critical pillar in the maturation of Israel’s business sector
08.09.25
|
Tomer Raved
Smart foreign capital that recognizes the resilience and maturity of Israeli companies, even amid persistent security uncertainty, can strengthen traditional industries, reduce leverage, and firmly position Israel on the global growth map.
Tectonic shifts are forcing venture capital to abandon the traditional model to survive
03.06.25
|
Meir Orbach, Sophie Shulman
The collapse of the classic startup playbook is forcing a fundamental reinvention.
Are Israel’s institutional investors late to the tech investment party?
24.03.21
|
Golan Hazani
Senior executives at The Phoenix explain their strategy when it comes to investments in private companies and admit they missed the insurtech craze
Tel Aviv-based equity firm Catalyst appoints Lisya Bahar-Manoah as partner
03.08.20
|
Sophie Shulman
Before joining Catalyst, Bahar-Manoah held senior management positions at Israeli plastic products company Keter and pesticide manufacturer Adama
As Capital Flows and Market Matures, Israeli Entrepreneurs Dream Big
05.11.18
|
Hagar Ravet
While tech companies’ choose to stay private longer, a record number of privately held growth companies now call Israel home, some with a valuation topping $1 billion
Venture Capital Investments in Israel in 2018 on Track to Match or Outpace 2017
02.10.18
|
CTech
Private equity deals are also picking up again after last year, with a shift from IT to healthcare, according to a new analysis by Pitchbook editor Eric Burg
Israel is One of the Most Interesting Markets for Investment, Says Venture Capitalist Jeff Horing
19.03.18
|
Omer Kabir
“Israel is the highest density geography in our portfolio,” Mr. Horing, co-founder and managing director at Insight Venture Partners, said at Calcalist's Mind the Tech conference in New York
Private Equity Firm HarbourVest Announces Series of Promotions
05.03.18
|
Tofi Stoler
Among those promoted is Ilan Rosen, head of HarbourVest’s Tel Aviv office
Data Security Company Algosec Raises $36 Million
03.01.18
|
Tofi Stoler
The investment was led by private equity firm Claridge Israel, the local branch of international firm Claridge Investment Ltd.
Warburg Pincus Completes Tender Offer for Email Protection Company Cyren
26.12.17
|
Lilach Baumer
After payment, the private equity firm will own approximately 52% of outstanding Cyren Shares
Warburg Pincus Buys Stake in Email Protection Company Cyren
07.11.17
|
Dror Reich
The private equity acquired a 21.3% stake in Nasdaq-listed Cyren for $19.6 million and plans to increase ownership by buying up to 75% of the company’s shares
Cerberus, Advent Eye Teva's European Assets, Report Says
15.08.17
|
Calcalist
The private equity firms are taking an interest in Teva's European oncology and pain treatment assets, estimated at $700 million to 1$ billion, according to a Bloomberg report